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Mucosal-associated invariant T (MAIT) cells are 
characterized by the expression of a semi-invariant 
TCR that engages antigenic ligands restricted 
by the nonpolymorphic MHC-like molecule 
MR1. Human MAIT TCRs typically comprise 
a TRAV1-2/TRAJ33 gene–encoded  chain 
paired with a  chain constructed from TRBV20-1  
or TRBV6 family gene segments (Porcelli et al., 
1993; Tilloy et al., 1999; Reantragoon et al., 2013). 
In contrast to conventional  T cell popula-
tions, pathogen-reactive MAIT cells with effector 
capacity can be found in the human thymus 
(Gold et al., 2013). Moreover, their selection 
depends on hematopoietic cells rather than 
thymic epithelium (Treiner et al., 2005; Martin 
et al., 2009). Collectively, these attributes suggest 
that MAIT cells constitute an innate T cell subset 
with conserved recognition properties.
Despite these innate-like features, several lines 
of evidence support the hypothesis that pathogen- 
reactive MAIT cells adapt to their environment. 
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Mucosal-associated invariant T (MAIT) cells express a semi-invariant T cell receptor (TCR) 
that detects microbial metabolites presented by the nonpolymorphic major histocompatibility 
complex (MHC)–like molecule MR1. The highly conserved nature of MR1 in conjunction with 
biased MAIT TCR chain usage is widely thought to indicate limited ligand presentation and 
discrimination within a pattern-like recognition system. Here, we evaluated the TCR reper-
toire of MAIT cells responsive to three classes of microbes. Substantial diversity and hetero-
geneity were apparent across the functional MAIT cell repertoire as a whole, especially for 
TCR chain sequences. Moreover, different pathogen-specific responses were characterized 
by distinct TCR usage, both between and within individuals, suggesting that MAIT cell adap-
tation was a direct consequence of exposure to various exogenous MR1-restricted epitopes. 
In line with this interpretation, MAIT cell clones with distinct TCRs responded differentially 
to a riboflavin metabolite. These results suggest that MAIT cells can discriminate between 
pathogen-derived ligands in a clonotype-dependent manner, providing a basis for adaptive 
memory via recruitment of specific repertoires shaped by microbial exposure.
© 2014 Gold et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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Le Bourhis et al., 2010; Kjer-Nielsen et al., 2012). However, 
structural studies have revealed that MR1 is promiscuous in 
its ability to bind and present diverse ligands (Reantragoon et al., 
2012; López-Sagaseta et al., 2013a; Patel et al., 2013). Accord-
ingly, there may be discrete pathogen-associated ligands that 
are yet to be identified.
In this study, we evaluated the ex vivo TCR repertoire 
of pathogen-reactive MAIT cells responsive to Mycobacterium 
smegmatis, Salmonella typhimurium, and Candida albicans. Clo-
notype usage was complex and highly selective within indi-
viduals, suggesting a diverse array of MR1-restricted microbial 
ligands. Moreover, different pathogen-specific responses were 
characterized by distinct TCR repertoires, both between and 
within individuals. Direct evidence of MR1-restricted ligand 
discrimination at the clonal level further supported the po-
tential for unique patterns of pathogen recognition by MAIT 
cells. Collectively, these data provide a basis for specific TCR 
repertoire mobilization within an innate-like system shaped 
by previous microbial exposure.
RESULTS
The TCR repertoire of MAIT cells identified using an MR1 
tetramer loaded with the stimulatory vitamin B metabolite, 
rRL-6-CH2OH, was recently shown to be more heteroge-
neous than expected based on previous studies (Reantragoon 
et al., 2013). Moreover, MAIT cells can detect infection with 
a wide range of bacteria and fungi (Gold et al., 2010; 
Le Bourhis et al., 2010), which likely have diverse metabolic 
pathways. In this context, we aimed to determine the relation-
ship between TCR usage and pathogen discrimination.
In earlier work, we used limiting dilution analysis to 
generate a panel of Mycobacterium tuberculosis (Mtb)–reactive 
CD8+ MAIT cell clones (Gold et al., 2010). All of these 
clones expressed TRAV1-2+ TCRs and recognized Mtb-in-
fected cells in an MR1-restricted manner as determined by 
V7.2-specific mAb staining and functional blockade with an 
MR1 mAb, respectively (not depicted; Gold et al., 2010). 
Sequence analysis confirmed this finding and further revealed 
that the majority of clones also incorporated the canonical 
TRAJ33 gene segment (Table 1). However, 4/16 clones ex-
pressed TRAJ20 (Gold et al., 2010), suggesting that pathogen-
reactive MAIT cells could yield additional TCR specificities. 
Moreover, we observed that MAIT cells from different indi-
viduals segregated into TCR families through preferential 
pairing of specific TCR and TCR chains (Table 1). For 
example, clones A9 and F9-2 from donors 481 and 504, re-
spectively, expressed identical TRAV1-2/TRAJ33+  chains 
paired with TRBV20-1+  chains.
To extend these findings beyond the Mtb-specific setting, 
we used an unbiased molecular approach to evaluate the MAIT 
TCR repertoire across diverse bacterial and fungal species. 
Peripheral blood CD8+ T cells from four unrelated adult 
donors were stimulated directly ex vivo by exposure to A549 
epithelial cells infected with M. smegmatis, S. typhimurium, or 
C. albicans to identify pathogen-reactive MAIT cells restricted by 
MR1 (Gold et al., 2010, 2013). Functionally responsive MAIT 
It is established that MAIT cells detect a broad range of mi-
croorganisms (Gold et al., 2010; Le Bourhis et al., 2010) and 
contribute to the control of several pathogens in mice, in-
cluding Klebsiella pneumoniae (Georgel et al., 2011), Francisella 
tularensis (Meierovics et al., 2013), and mycobacterial species 
(Le Bourhis et al., 2010; Chua et al., 2012). Furthermore, 
MAIT cells expand in the periphery after thymic egress as a 
consequence of microbial colonization (Martin et al., 2009; 
Le Bourhis et al., 2010). In line with these observations, 
human MAIT cells display a naive phenotype in cord blood 
but acquire characteristics associated with exogenous antigen 
exposure in adults (Dusseaux et al., 2011; Gold et al., 2013). 
However, the microbial and environmental signals that lead to 
the migration, differentiation, expansion, and maintenance of 
MAIT cells are not understood.
Although the MAIT TCR has been described as semi- 
invariant, there is sufficient plasticity within the repertoire to 
allow for the possibility of diverse ligand recognition. Indeed, 
MAIT TCRs are not exclusively germline-encoded and in-
corporate sequence variability as a consequence of V(D)J 
recombination (Tilloy et al., 1999; Greenaway et al., 2013; 
Reantragoon et al., 2013). This process of somatic gene rear-
rangement potentially enables pathogen-specific recognition 
within the confines of restricted TCR gene usage.
Recently, MR1 has been shown to bind small organic 
compounds derived from microbial vitamin B biosynthetic 
pathways (Kjer-Nielsen et al., 2012). Although MR1 binds 
metabolites of vitamin B9 (folic acid), only three derivatives of 
vitamin B2 (riboflavin), rRL-6-CH2OH, RL-6-Me-7-OH, 
and RL-6,7-diMe, are known to stimulate MAIT cells (Kjer-
Nielsen et al., 2012). Consistent with this observation, micro-
organisms with the capacity to synthesize riboflavin have been 
associated with MAIT cell activation (Gold et al., 2010; 
Table 1. Summary of TCR usage in human MAIT cell clones
Clone ID TRBV TRAJ CDR3
D470_B1a 20-1 20 CAVNGDDYKLSF
D481_F12 4-2 20 CAVRDSDYKLSF
D481_C7 6-4 20 CAVSLQDYKLSF
D571_A1 6-4 20 CAVRDGDYKLSF
D426_G11 6-4 33 CAVRDSNYQLIW
D426_B1a 6-4 33 CAVRDSNYQLIQW
D466_F5a 6-4 33 CAVRDSNYQLIQW
D571_A10-2 6-4 33 CAVRDSNYQLIW
D481_A9 20-1 33 CAAMDSNYQLIW
D504_F9-2 20-1 33 CAAMDSNYQLIW
D466_A3 20-1 33 CAVLDSNYQLIW
D450_C8a 6-2/3 33 CARSDSNYQLIW
D426_A6 6-4 33 CAVMDSNYQLIW
D426_G1 6-5 33 CAVSDSNYQLIW
D470_F6 6-6 33 CAALDSNYQLIW
D504_H11 17 33 CASMDSNYQLIW
Putative TCR families appear in bold and italics.
aPreviously described in Gold et al. (2010).
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identified. Of these noncanonical genes, TRAJ9 and TRAJ39 do 
not encode the Tyr95 residue present in TRAJ33, TRAJ20, and 
TRAJ12 (Reantragoon et al., 2013), which is thought to be criti-
cal for MAIT cell activation (Reantragoon et al., 2012; Patel et al., 
2013; Young et al., 2013). Due to the lack of allelic exclusion at the 
TRA locus, however, we cannot definitively assign these  chains 
to functional heterodimeric TCRs.
Notable differences in TRAJ gene usage were apparent 
across pathogen-reactive MAIT cell populations. In terms of 
overall distribution, diversity was greatest for S. typhimurium 
and most restricted for C. albicans. Individual TRAJ gene usage 
also differed across specificities within each individual. This 
was most striking in donor 520 (D520). Here, TRAV1-2/
TRAJ33 gene–encoded TCRs were elicited in response to 
M. smegmatis and S. typhimurium, but not in response to C. albi-
cans. Collectively, these data demonstrate that pathogen-reactive 
TRAV1-2+ MAIT cells can productively incorporate a broad 
array of TRAJ gene segments with differential usage across 
pathogen specificities.
cells were isolated for repertoire experiments at high purity using 
a flow cytometric sorting strategy to detect viable TRAV1-2+ 
cells expressing TNF (Haney et al., 2011). Response sizes var-
ied from 0.5 to 6.9% of the TRAV1-2+ CD8+ T cell population 
with no significant differences between pathogens. Clonotypic 
analysis was then performed using a template switch–anchored 
RT-PCR as described previously (Quigley et al., 2011).
An aggregated analysis of TRAJ gene usage by pathogen-
reactive TRAV1-2+ MAIT TCRs is shown in Fig. 1. Although 
the canonical TRAV1-2/TRAJ33 rearrangement dominated the 
TCR chain repertoire, alternative TRAJ genes were commonly 
used. In particular, substantial proportions of the TRAV1-2/non-
TRAJ33 rearrangements incorporated TRAJ20 or TRAJ12 seg-
ments. Moreover, an array of TRAJ genes not previously known 
to associate with pathogen-reactive, TRAV1-2+ MAIT cells were 
Figure 1. Pathogen-reactive MAIT TCR chains are not confined 
to TRAV1-2/TRAJ33 rearrangements. Human CD8+ MAIT cells from 
four individuals were stimulated overnight using A549 cells infected with 
M. smegmatis, S. typhimurium, or C. albicans. Live, pathogen-reactive 
MAIT cells were then isolated by flow cytometry based on coexpression of 
TRAV1-2 and TNF. Unbiased molecular analysis of expressed TRA gene 
products was performed as described in Materials and methods. Aggre-
gate TRAJ gene profiles from all four donors in response to each patho-
gen (n = 3) are shown at the top; data from individual donors are shown 
underneath as indicated. Each sequence was counted once regardless of 
frequency. Total sequence counts are indicated in each case.
Figure 2. Pathogen-reactive MAIT TCR chains are diverse. Details 
as described in the legend to Fig. 1, except that TRBV gene usage was ana-
lyzed. Aggregate TRBV gene profiles from all four donors in response to 
each pathogen (n = 3) are shown at the top; data from individual donors 
are shown underneath as indicated. Each sequence was counted once re-
gardless of frequency. Total sequence counts are indicated in each case.
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expressed a diverse array of TRBV genes without apparent en-
richments (not depicted). As above, TRBV gene usage was most 
diverse for S. typhimurium and varied across specificities within 
each individual. In D520, for example, the MAIT cell response 
to C. albicans was composed entirely of TRBV20-1+ TCRs, 
yet these were relatively rare in the corresponding responses 
A similar analysis is shown for TRBV gene usage in Fig. 2. 
Across the dataset as a whole, 35 different TRBV genes were 
represented within the pathogen-reactive MAIT cell reper-
toire. Most frequent among these were the TRBV20-1 and 
TRBV6 family gene members. In contrast, these TRBV genes 
were used by <6% of nonresponsive TRAV1-2+ cells, which 
Figure 3. MAIT TRAV1-2+ CDR3 sequences 
display length and sequence similarity. (A) Rep-
resentation of unique TRAV1-2+ CDR3 se-
quences from each donor in response to each 
pathogen as indicated. Each bar represents a 
distinct sequence, the relative frequency of which 
is depicted on the y axis. TRAJ gene usage is 
shown on the x axis labeled for dominant se-
quences. (B) Distribution of CDR3 amino acid 
lengths from TRAV1-2+ MAIT cells responsive to 
each pathogen as indicated in the key. (C) Visual 
representation of amino acid enrichments at each 
position across the CDR3 core compiled from 
pathogen-reactive MAIT cell TRAV1-2+ sequences. 
Analysis was confined to CDR3 sequences with 
a length of 11 amino acids, encompassing 39 
sequences for M. smegmatis, 61 for S. typhimurium, 
and 30 for C. albicans. Graphics were generated 
using Seq2Logo.
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chains can discriminate between ligands. Although we have 
no knowledge of each individual’s microbial exposure history, 
the repertoire observed for any particular microbial pathogen 
may reflect prior ligand exposure. At present, the precise na-
ture of such MR1-restricted antigens and their relationship to 
TCR usage remains unknown.
To assess true clonotypic diversity, we similarly evaluated 
TCR chain usage across donors and specificities (Fig. 4). For 
this purpose, we selected TRBV20-1+ sequences, which rep-
resent the most common TRBV gene–defined clonotypes across 
pathogen-reactive MAIT cells. As above, unique TRBV20-1+ 
sequences were associated with each pathogen specificity. In 
D497, for example, MAIT cell populations specific for S. ty-
phimurium and C. albicans incorporated different CDR3 loops 
despite equivalent TRBV20-1 gene usage (Fig. 4 A); these 
sequences were further distinct from those responsive to M. 
smegmatis (Fig. 4 A). Similar findings applied to other TRBV 
gene families (not depicted). Moreover, across the entire data-
set, only four shared TCR clonotypes were detected between 
donors; notably, each of these sequences was associated with 
more than one pathogen specificity (not depicted). Thus, in 
sharp contrast to the TCR chain repertoire, minimal TCR 
overlap was present across donors and pathogens.
to S. typhimurium and M. smegmatis. Thus, MAIT cells use di-
verse TRBV gene segments with variable clonotypic deploy-
ment across pathogen specificities.
Previous studies have demonstrated that MAIT TCR 
chains are not exclusively germline encoded (Tilloy et al., 
1999; Treiner et al., 2005; Gold et al., 2010; Goldfinch et al., 
2010) and most often contain single nucleotide additions that 
contribute to CDR3 core diversity (Greenaway et al., 2013). 
We therefore performed an in-depth analysis of CDR3 se-
quences across our dataset (Fig. 3).
Unique CDR3 sequences within the TRAV1-2+ reper-
toire are displayed across donors and specificities in Fig. 3 A. 
In these graphics, each bar represents a distinct sequence plot-
ted as a function of TRAJ gene usage (x axis) and relative fre-
quency (y axis). Disparate patterns were observed, suggesting 
pathogen-specific MAIT cell reactivity. In D497, for example, M. 
smegmatis and C. albicans elicited three predominant TRAV1-2+ 
sequences that were distinct from one another; a broader rep-
ertoire was activated in response to S. typhimurium, which 
again differed at the level of CDR3 sequence usage. Simi-
larly, the TRAV1-2+ MAIT cell response to C. albicans was dom-
inated by two unique sequences in D520, whereas broader 
repertoires were elicited by M. smegmatis and S. typhimurium. 
Thus, the MAIT cell response to each of these microbes was 
characterized by unique TCR usage within individuals.
Although no unique TRAV1-2+ sequence appeared to 
associate with a single pathogen or a single donor, we wanted 
to evaluate patterns of amino acid usage across pathogen speci-
ficities. To perform this analysis on the greatest number of 
TRAV1-2+ transcripts, we selected CDR3 sequences con-
taining 11 amino acid residues (Fig. 3 B). This subset contained 
39 sequences for M. smegmatis, 61 for S. typhimurium, and 30 
for C. albicans. Representative logos highlighting preferential 
amino acid usage for each pathogen are shown in Fig. 3 C. 
Particular amino acid motifs were prevalent within the TRAV1-2+ 
sequences for each pathogen. For example, tyrosine (Y) was 
highly prevalent at position 8 in C. albicans–reactive MAIT 
cells, whereas glycine (G) was favored at position 7 for S. ty-
phimurium. To quantify this observation further, we compared 
the similarity of TRAV1-2+ sequences within a given group, 
defined by donor or pathogen, to the corresponding sequence 
similarity between groups (Shen et al., 2012). The analysis 
across donors shown in Table 2 (A) demonstrates two points. 
First, overall similarity is high, given that a value of 1 repre-
sents 100% similarity. Second, similarity within each donor is 
consistently greater than the similarity between donors. Similar 
patterns were observed across pathogen specificities (Table 2, B). 
The significance of these analyses was evaluated using an 
exact permutation test. Here, each observed TRAV1-2+ se-
quence was randomly assigned to a donor-pathogen pair to 
determine whether such associations could lead to a result 
where the similarity within donors and pathogens (intrasimi-
larity) was consistently higher than the similarity between 
donors and pathogens (intersimilarity). None of the permuta-
tions across 1,000 rounds resulted in higher intersimilarity 
(P < 0.001). Collectively, these data suggest that MAIT TCR 
Table 2. Similarity analyses of TRAV1-2+ CDR3 sequences
Group 1 Group 2 Similarity
(A) Similarity analysis across individuals
D497 D497 0.947
D497 D518 0.940
D497 D520 0.935
D497 D674 0.942
D518 D497 0.899
D518 D518 0.912
D518 D520 0.901
D518 D674 0.905
D520 D497 0.858
D520 D518 0.866
D520 D520 0.903
D520 D674 0.861
D674 D497 0.906
D674 D518 0.913
D674 D520 0.907
D674 D674 0.923
(B) Similarity analyses across pathogens
C. albicans C. albicans 0.934
C. albicans S. typhimurium 0.925
C. albicans M. smegmatis 0.927
S. typhimurium C. albicans 0.896
S. typhimurium S. typhimurium 0.906
S. typhimurium M. smegmatis 0.902
M. smegmatis C. albicans 0.901
M. smegmatis S. typhimurium 0.910
M. smegmatis M. smegmatis 0.916
Bolded values denote those with the highest similarity within each comparison group.
o
n
 June 13, 2017
D
ow
nloaded from
 
Published July 21, 2014
1606 MAIT cells display pathogen selectivity | Gold et al.
TRBJ gene–encoded phenylalanine (F) and tyrosine (Y) resi-
dues were notably represented at the C terminus, potentially 
reflecting amino acid conservation linked to preferential usage 
of TRBJ1-1, TRBJ2-1, and TRBJ2-7 (Fig. 4 C). To extend 
these observations, we performed similarity analyses for the 
most common TRBV gene–defined clonotypes in our dataset 
To evaluate amino acid usage across specificities, we selected 
all clonotypes with CDR3 sequences containing 13 or 14 
residues, based on prevalence within the length distribution 
profile (Fig. 4 B). This subset contained 34 sequences for 
M. smegmatis, 75 for S. typhimurium, and 39 for C. albicans. No 
obvious motifs were present across the CDR3 core, although 
Figure 4. MAIT CDR3 usage is unique 
across individuals and pathogens. (A) Repre-
sentation of unique TRBV20-1+ CDR3 sequences 
from each donor in response to each pathogen as 
indicated. Each bar represents a distinct sequence, 
the relative frequency of which is depicted on the 
y axis. TRBJ gene usage is shown on the x axis 
labeled for dominant sequences. (B) Distribution 
of CDR3 amino acid lengths from all TRBV 
gene–defined MAIT cells responsive to each 
pathogen as indicated in the key. (C) Visual repre-
sentation of amino acid enrichments at each 
position across the CDR3 core compiled from 
pathogen-reactive MAIT cell TRBV+ sequences. 
Analysis was confined to CDR3 sequences with 
a length of 13 or 14 amino acids, encompassing 
34 sequences for M. smegmatis, 75 for S. typhi­
murium, and 39 for C. albicans. Graphics were 
generated using Seq2Logo.
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(Porcelli et al., 1993; Tilloy et al., 1999). Additional TCR 
complexity was subsequently demonstrated in Mtb-reactive 
MAIT cell clones (Gold et al., 2010) and more recently in 
rRL-6-CH2OH/MR1 tetramer–reactive cells (Reantragoon 
et al., 2013). In line with the latter study, pathogen-reactive 
MAIT cells frequently expressed TRAJ33, TRAJ12, and 
TRAJ20 gene transcripts. Each of these genes encodes the 
Tyr95 residue thought to be essential for MR1-restricted li-
gand recognition (Reantragoon et al., 2012; López-Sagaseta 
et al., 2013a; Patel et al., 2013). Our study identifies two addi-
tional TRAJ genes, namely TRAJ41 and TRAJ28, which also 
encode Tyr95 in MAIT cells. Further TRAJ gene transcripts, 
(TRBV20-1, TRBV6-1, TRBV6-2/3, and TRBV28), com-
prising a total of 148 unique sequences across all donors and 
pathogens (Table 3, A and B). Again, the similarity indices 
were consistently high, but nevertheless lower than for the 
TRAV1-2+ sequences, reflecting a more diverse TCR rep-
ertoire. Furthermore, intrasimilarity was significantly greater 
than intersimilarity for all TRBV gene–defined comparison 
groups across donors (Table 3, A) and pathogens (Table 3, B). 
This latter observation is particularly remarkable in the case 
of S. typhimurium, which mobilized a highly diverse set of 
TCR clonotypes (median Simpson’s diversity index, 0.934–
0.983) compared with M. smegmatis and C. albicans (median 
Simpson’s diversity index, 0.221/0.184 to 0.971/0.966, re-
spectively). Finally, we compared the similarity of TRBV 
gene–defined sequences in TRAV1-2+ nonreactive (TNF) 
cells isolated during the C. albicans stimulation protocol with 
the corresponding pathogen-reactive (TNF+) populations. 
The greatest level of similarity was observed among the non-
reactive TRAV1-2+ cells (Table 3, C). Collectively, these analy-
ses support the conclusion that different pathogen-associated 
antigens drive distinct donor-specific TCR clonotype ex-
pansions within the MAIT cell population.
To confirm this hypothesis, we tested four TCR-distinct 
MAIT cell clones (Table 1; Gold et al., 2010) for reactivity against 
the riboflavin-derived MR1-restricted ligand RL-6,7-diMe 
(Kjer-Nielsen et al., 2012) in IFN- ELISPOT assays. Only 
two clones recognized RL-6,7-diMe (Fig. 5 A), even though 
all four were comparably stimulated by presenting cells in-
fected with M. smegmatis. The stronger agonist rRL-6-CH2OH 
was not tested (Kjer-Nielsen et al., 2012; Corbett et al., 2014). 
Moreover, each clone responded similarly to each of the three 
pathogens used for TCR analysis (Fig. 5 B). Notably, all four 
clones contain the Tyr95 residue thought to be essential for 
MR1-restricted recognition (Reantragoon et al., 2012; Patel 
et al., 2013; Young et al., 2013). Nevertheless, this character-
istic in isolation was not sufficient for universal activation by 
RL-6,7-diMe. Thus, MAIT cells can discriminate between 
MR1-restricted ligands.
DISCUSSION
In this study, we evaluated the ex vivo TCR repertoire of 
MAIT cells responsive to three distinct classes of pathogens. 
Substantial diversity and heterogeneity were apparent across 
the functional MAIT cell repertoire as a whole, especially for 
TCR chain sequences. Moreover, different pathogen-specific 
responses were characterized by distinct TCR usage, both 
between and within individuals, suggesting that MAIT cell 
adaptation was a direct consequence of exposure to various 
exogenous MR1-restricted epitopes. In line with this inter-
pretation, MAIT cell clones with distinct TCRs responded 
differentially to a riboflavin metabolite. These results suggest 
that MAIT cells can discriminate between pathogen-derived 
ligands in a clonotype-dependent manner, potentially enabling 
adaptive memory within a pattern-like recognition system.
MAIT cells were originally defined by the expression of a 
canonical semi-invariant TRAV1-2/TRAJ33 TCR chain 
Table 3. Similarity analyses of TRBV6-1+, TRBV6-2/3+, 
TRBV20-1+, and TRBV28+ CDR3 sequences
Group 1 Group 2 Similarity
(A) Similarity analyses across individuals
D497 D497 0.858
D497 D518 0.840
D497 D520 0.838
D497 D674 0.852
D518 D497 0.852
D518 D518 0.859
D518 D520 0.838
D518 D674 0.849
D520 D497 0.841
D520 D518 0.830
D520 D520 0.850
D520 D674 0.837
D674 D497 0.849
D674 D518 0.837
D674 D520 0.833
D674 D674 0.858
(B) Similarity analyses across pathogens
C. albicans C. albicans 0.861
C. albicans S. typhimurium 0.855
C. albicans M. smegmatis 0.842
C. albicans TRAV1-2+ TNF 0.853
S. typhimurium C. albicans 0.842
S. typhimurium S. typhimurium 0.855
S. typhimurium M. smegmatis 0.838
S. typhimurium TRAV1-2+ TNF 0.847
M. smegmatis C. albicans 0.843
M. smegmatis S. typhimurium 0.853
M. smegmatis M. smegmatis 0.869
M. smegmatis TRAV1-2+ TNF 0.848
(C) Similarity analyses across nonreactive (TNF) and pathogen-
reactive (TNF+) subsets
TRAV1-2+ TNF M. smegmatis 0.844
TRAV1-2+ TNF S. typhimurium 0.857
TRAV1-2+ TNF C. albicans 0.845
TRAV1-2+ TNF TRAV1-2+ TNF 0.858
Bolded values denote those with the highest similarity within each comparison group.
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at the TRA locus precludes definitive conclusions. Nonethe-
less, the TCR repertoire of MAIT cells is clearly more di-
verse than previously described and shows features consistent 
with pathogen selectivity.
Historically, MAIT cells have been associated with 
TRBV20-1 and TRBV6 family genes (Porcelli et al., 1993; 
Tilloy et al., 1999). More recently, 75% of tetramer-reactive 
MAIT cells were found to express these TRBV genes despite 
the presence of additional heterogeneity (Reantragoon et al., 
2013). Although pathogen-reactive MAIT cells frequently 
displayed TRBV20-1 and TRBV6 family gene usage in our 
study, >50% of all TRBV family genes were also detected, re-
vealing greater heterogeneity than observed previously. These 
findings could indicate promiscuous pairing or the potential 
for diverse ligand recognition mediated by the TCR chain. 
The extent to which the TCRV domain contributes to li-
gand discrimination remains unclear. Mutagenesis of specific 
residues in the CDR3 loop did not alter MAIT hybridoma 
cell recognition of MR1-overexpressing cells loaded with Sal-
monella supernatants; however, TCRV chain swapping abro-
gated recognition by the same hybridoma (Reantragoon et al., 
2012). These data suggest that the TCRV domain contrib-
utes to MR1-restricted ligand recognition in ways that remain 
to be defined. At present, our ex vivo analysis of pathogen- 
reactive MAIT cells precludes the assignment of  pairing. 
Nonetheless, limited analysis of Mtb-reactive clones points to 
segregation of MAIT cells into TCR families through prefer-
ential pairing of specific TCR and TCR chains. For ex-
ample, MAIT cell clones with identical CDR3 chains 
isolated from different individuals tended to associate with 
the same TRBV gene family. Such putative TCR families 
may, at least in theory, contribute to greater affinities for spe-
cific classes of antigen. Indeed, the observation that only four 
TCR sequences were shared across our entire dataset sug-
gests that clonotypic expansions occur in a manner similar to 
conventional T cells. Accordingly, the observation of unique 
TRBV gene usage across pathogens suggests that TCR 
chains contribute to ligand detection. This conclusion is sup-
ported by molecular analyses of MAIT TCR engagement 
with MR1-presented ligands (Reantragoon et al., 2012; 
López-Sagaseta et al., 2013a,b; Patel et al., 2013; Young et al., 
2013), which have revealed a docking mode similar to that of 
classical MHC-restricted  TCRs and unlike that used by 
CD1-restricted iNKT cells (Reantragoon et al., 2012; López-
Sagaseta et al., 2013a,b; Patel et al., 2013). In this case, the less 
variable TCR chain primarily mediates contacts with the 
MR1 protein, whereas the CDR3 loop is positioned above 
the MR1 ligand–binding groove. As suggested previously 
(López-Sagaseta et al., 2013a,b), this topography lends itself 
to the interpretation that the CDR3 loop can contribute to 
ligand discrimination.
Based on our findings, we postulate that MR1-restricted 
ligand diversity drives MAIT cell adaptation and TCR reper-
toire diversity. Although not yet described, we presume that the 
naive MAIT thymocyte population contains a diverse and un-
focused precursor repertoire. Subsequently, skewed clonotypic 
such as TRAJ9 and TRAJ39, were detected that do not en-
code Tyr95. In one donor (D520), these two genes domi-
nated TRAJ usage in MAIT cells responsive to C. albicans, but 
not M. smegmatis or S. typhimurium, suggesting alternative modes 
of TCR engagement. However, the lack of allelic exclusion 
Figure 5. MR1-restricted MAIT cell clones display ligand discrimi-
nation for the vitamin B metabolite RL-6,7-diMe. (A) A549 cells 
(20,000 per well) were pulsed with 5 µg/ml RL-6,7-diMe overnight and 
tested for their ability to stimulate MR1-restricted clones (10,000 per 
well) in IFN- ELISPOT assays. Clones D426 B1 and D481 A9 express 
TRAJ33; clones D481 F12 and D481 C7 express TRAJ20. TRBV usage and 
CDR3 and CDR3 sequences are indicated. Error bars represent SEM of 
duplicate determinations. (B) A549 cells (25,000 per well) were infected 
with S. typhimurium, C. albicans, or M. smegmatis at an MOI of 50 (hi), 25 
(med), or 12.5 (lo) and then incubated overnight with the indicated MR1-
restricted MAIT cell clones (10,000 per well) in duplicate wells. IFN- pro-
duction was quantified by ELISPOT. Similar results were obtained from a 
minimum of three independent experiments.
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Microorganisms and infection of A549 cells. Adherent A549 cells were 
infected overnight with M. smegmatis (multiplicity of infection [MOI] 10), 
and nonadherent A549 cells were infected for 1 h with S. typhimurium (MOI 
30) or C. albicans (MOI 3) at 37°C. All infections were performed in the ab-
sence of antibiotics.
Stimulation and isolation of pathogen-reactive MAIT cells. CD8+  
T cells were enriched from PBMCs by negative selection using magnetic bead 
separation according to the manufacturer’s instructions (STEMCELL Tech-
nologies), added to uninfected or infected A549 cells at a ratio of 3:1, and in-
cubated for 16 h in the presence of -TNF (Beckman Coulter) and TAPI-O 
(EMD Millipore) to prevent TNF cleavage from the cell surface (Haney et al., 
2011). The following day, cells were stained with: (a) -CD4 and -CD8 
(BioLegend) and (b) –TRAV1-2 and –TCR (Thermo Fisher Scien-
tific). Dead cells were excluded from the analysis using propidium iodide 
(BioLegend). Viable CD4TCRCD8+TRAV1-2+TNF+ cells were sorted 
at high purity using a FACSAria flow cytometer (BD) directly into RNAl-
ater (Applied Biosystems). The corresponding nonfunctional populations 
were sorted in parallel for control purposes. In all cases, cell numbers were 
standardized (5,000 per aliquot) to minimize sampling bias.
Molecular analysis of TCR usage. Clonotypic analysis of sorted cell popu-
lations was performed as described previously (Quigley et al., 2011). In brief, 
unbiased amplification of all expressed TRB or TRA gene products was 
conducted using a template switch–anchored RT-PCR with chain-specific 
constant region primers. Amplicons were subcloned, sampled, sequenced, and 
analyzed as described previously (Price et al., 2005). The IMGT nomencla-
ture is used in this study (Lefranc et al., 2003).
Construction of sequence logos. Sequence logos were generated in 
Shannon format without the use of pseudo counts via the Seq2Logo web-
server (Thomsen and Nielsen, 2012). Shannon sequence logos give a visual 
representation of amino acid enrichments at different positions in the ob-
served CDR3 sequences. The different amino acids are colored according to 
physicochemical properties (acidic [DE], red; basic [HKR], blue; hydropho-
bic [ACFILMPVW], black; and neutral [GNQSTY], green). For TRAV1-2, 
only sequences with a length of 11 amino acids were included (39 sequences 
for M. smegmatis, 61 for S. typhimurium, and 30 for C. albicans). For TRBV, only 
sequences with a length of 13 or 14 amino acids were included (34 sequences 
for M. smegmatis, 75 for S. typhimurium, and 39 for C. albicans). The TRBV 
sequences were aligned using ClustalX (Larkin et al., 2007) with default 
parameters set before logo generation. The width of each bar in the sequence 
logo corresponds inversely with gap density at the given positions.
CDR3 sequence similarity. Similarity between CDR3 sequences was 
calculated as described previously (Shen et al., 2012). This method allows 
similarities to be assigned between sequences of different length in an align-
ment-free manner. In this similarity measure, a perfect match has a similarity 
score of 1, and a perfect mismatch has a similarity score of 0. To calculate the 
similarity between two groups of sequences, each sequence from the first 
group was assigned a score corresponding to the best match against all se-
quences from the other group (excluding identical matches), and the similar-
ity between the two groups was calculated as the mean of these similarity 
measures over all sequences within the first group.
CDR3 sequence diversity. Simpson’s diversity index was calculated using 
the randomization method as described previously (Venturi et al., 2007). The 
median value for each population was derived from 10,000 random draws 
standardized to the lowest sample size.
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responses to different pathogens emerge in the periphery as a 
result of antigenic exposure to a diverse array of MR1-restricted 
ligands. We further propose that these expansions will reflect 
distinct microbial challenges. This scenario of differential ago-
nist encounter would explain the unique clonotypic expan-
sions across individuals with different microbial exposure 
histories. In line with this hypothesis, increased MAIT TCR 
engagement through the CDR3 loop was recently associ-
ated with greater MR1-restricted ligand potency (López-
Sagaseta et al., 2013b; Patel et al., 2013). Thus, patterns of 
clonotypic expansion are likely to reflect high-affinity TCR 
interactions with distinct MR1 ligands, consistent with previ-
ous observations in conventional systems (Price et al., 2005).
Although the possibility exists that stimulatory micro-
organisms express the same few MR1-restricted riboflavin li-
gands in different proportions, elegant molecular analyses provide 
evidence that MR1 can accommodate a range of different li-
gands (Reantragoon et al., 2012; López-Sagaseta et al., 2013a; 
Patel et al., 2013). To date, only three MAIT cell epitopes have 
been identified, all of which are riboflavin metabolites (Kjer-
Nielsen et al., 2012; Reantragoon et al., 2012, 2013; Patel 
et al., 2013). Nonetheless, these antigens share many chemical 
properties with other microbial and mammalian compounds. 
It is therefore highly feasible that other MR1-restricted ligands 
are generated similarly, enabling MAIT cell adaptation to a wide 
range of microorganisms and their associated metabolomes.
Pathogen-reactive MAIT cells share many features tradi-
tionally thought to be associated with both innate and adaptive 
T cells. Restriction by a nonpolymorphic MHC-like mole-
cule, expression of a semi-invariant TCR, thymically acquired 
effector function, and intrathymic selection by hematopoietic 
cells are all considered features of innate T cells. However, 
after thymic egress, MAIT cells expand and acquire an effector 
phenotype associated with antigenic exposure. Furthermore, the 
development of MAIT cells requires the presence of bacteria, 
suggesting the capacity to adapt in response to environmental 
signals. Our data provide evidence that MAIT cells can detect 
a diverse array of MR1-restricted ligands and differentiate se-
lectively in response to specific pathogens akin to classically 
restricted T cells. Thus, the MAIT TCR enables adaptive im-
mune responses within the confines of a pattern-like recogni-
tion system that can discriminate between microorganisms.
MATERIALS AND METHODS
Human subjects. All samples were collected under protocols approved by 
the Institutional Review Board at Oregon Health and Science University. 
PBMCs were obtained by apheresis from healthy adult donors with informed 
consent. Subjects lacked any detectable responses to the immunodominant 
Mtb antigens CFP-10 and ESAT-6 and were considered unexposed. Expo-
sure to M. smegmatis, S. typhimurium, and C. albicans was not evaluated.
Cells and reagents. A549 cells (ATCC CCL-185) were used as stimulators 
for direct ex vivo determination of Mtb-reactive T cells. Mtb-specific MAIT 
cell clones were generated, maintained, and tested by IFN- ELISPOT as 
described previously (Gold et al., 2010). All of these clones expressed TRAV1-
2+ TCRs and recognized pathogen-infected cells in an MR1-restricted man-
ner. RL-6,7-diMe was purchased from WuXi AppTec.
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